The program that keeps watch over the management of dangerous pathogens at research laboratories still isn’t up to snuff, according to a new report from the U.S. Government Accountability Office (GAO).GAO’s acting director for health care, Mary Denigan-Macauley, will discuss the findings at a hearing of the U.S. House of Representatives Energy and Commerce Committee’s oversight and investigations subcommittee on Thursday, alongside representatives of CDC and APHIS.
Office of Strategic Communication